Close Menu

NEW YORK (360Dx) – Bluejay Diagnostics said today that it has entered into a two-year cooperative research and development agreement (CRADA) with the US Naval Medical Research Center to develop a non-invasive point-of-care test for early-stage detection of Lyme disease.

The collaboration will focus on the study of antigens associated with various pathogens and identifying the most immunoreactive antigen — information that the collaborators will use to develop a rapid test for the detection of pathogen antigens in biofluids, including serum and urine.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.